Gail K. Naughton, Ph.D., has been the Dean of the College of Business Administration at San Diego State University since August 2002. Prior to that, she spent more than 15 years at Advanced Tissue Sciences, where she was the company’s co-founder and co-inventor of its core technology. During her tenure there, Dr. Naughton held a variety of key management positions, including president, chief operating officer, chief scientific officer and principal scientist. While serving as an officer and director of the Company, Dr. Naughton oversaw the design and development of the world’s first up-scaled manufacturing facility for tissue engineered products, established corporate development and marketing partnerships with companies including Smith & Nephew, Ltd., Medtronic and Inamed Corporation, was pivotal in raising over $350M from the public market and corporate partnerships, and brought four products from concept through FDA approval and market launch. Dr. Naughton holds over 90 U.S. and foreign patents and has been extensively published in the field of tissue engineering. In 2000, Dr. Naughton received the 27th Annual National Inventor of the Year award by the Intellectual Property Owners Association in honor of her pioneering work in the field of tissue engineering.

In addition to her duties at San Diego State University, Dr. Naughton serves as a director for several not-for-profit foundations including the City of Hope. She also sits on the scientific and industry advisory boards of leading universities including the Georgia Institute of Technology, and is a member of the Board of Directors of the California Health Institute, the San Diego World Trade Center, and the San Diego State University Corporate Governance Institute as well as being a member of the Mayor’s Science & Technology Council, and Rotary International. She is currently on the board of one private biotechnology company: DermTech International and two public companies, C.R. Bard, Inc. and SYS Technologies Inc.

Dr. Naughton earned her Ph.D. in Basic Medical Sciences and her M.S. in histology from the New York University Medical Center. She earned an executive MBA in 2001 from the Anderson School at the University of California, Los Angeles.